Lanean...
NEDD8 and HDACs: promising cotargets in AML
In this issue of Blood, Zhou et al have identified synergistic in vitro and in vivo anti–acute myeloid leukemia (AML) activity of the lysine neddylation inhibitor pevonedistat and pan–histone deacetylase (HDAC) inhibitor (pan-HDACI) belinostat and examine the mechanisms responsible for this synergis...
Gorde:
| Argitaratua izan da: | Blood |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4859193/ https://ncbi.nlm.nih.gov/pubmed/27151736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-02-699058 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|